Biolife in May launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. While hemostat products have been introduced into the first aid set before, this is the first one targeting patients on a specific therapy.
Top-level executives from more than a dozen major U.S. companies on Monday joined with government officials to launch a nationwide public-private sector initiative to advance employment of people with disabilities.
A worldwide provider of managed videoconferencing, telepresence and visual collaboration services has partnered with Telemed Ventures to deliver a managed visual collaboration solution to Walmart's retail medical clinics.
First-quarter profits at Walmart exceeded analysts’ estimates as same-store sales increased 2.6% and the company said its strategy of low prices on a broad merchandise assortment is resonating again with shoppers.
HumanKind Water, PlateTopper and SnapIt Eyeglass Repair Kit have the distinction of being the winners of Walmart's Get on the Shelf contest — beating out more than 4,000 inventors, entrepreneurs and small businesses to claim the coveted prize of being carried in Walmart's U.S. stores, as well as on Walmart.com.
The Network of Executive Women is honoring Mike Duke, president and CEO of Wal-Mart Stores, with its William J. Grize Diversity Hall of Fame Award, on June 28 during Women's Day at the LPGA in Rogers, Ark.
Walmart announced that Google's VP local and maps Marissa Mayer will be up for election to the board at the company's annual shareholders' meeting on June 1. If elected, Mayer would become the 16th member of the board.
Walmart and healthcare partner Humana are out with a new prescription drug program called Rx4Value that guarantees savings and relies on the proven strategy of improving affordability by restricting choice to generic drugs.
“We want to make sure we’re talking to our members where and how they want to be spoken to.” That was something Sam’s Club VP health and family care Jason Reiser said to me for the special report we did on the company that appeared on the cover of our April 2 issue.